SCHEMBL26211765

SCHEMBL26211765

CC(C)NC(C)(C)C(=O)N[C@H](Cc1cccc2ccccc12)C(=O)NCC(=O)NCC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1cccc2ccccc12)C(=O)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 4/20 0.49
▸ CTSS P25774 1/20 0.44
▸ CTSK P43235 1/20 0.44
▸ PSMB5 P28074 4/20 0.44
▸ PSMB8 P28062 3/20 0.44
▸ HRH4 Q9H3N8 1/20 0.44
▸ MMP9 P14780 2/20 0.42
▸ MMP8 P22894 2/20 0.42
▸ MMP14 P50281 1/20 0.42
▸ OPRM1 P35372 2/20 0.42
▸ OPRK1 P41145 1/20 0.42
▸ CTSB P07858 1/20 0.42
▸ CTSD P07339 1/20 0.41
▸ MME P08473 1/20 0.41
▸ ACE P12821 1/20 0.41
▸ CPA1 P15085 1/20 0.41
▸ ACE2 Q9BYF1 1/20 0.41
▸ LCK P06239 2/20 0.40
▸ MMP2 P08253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26211712 0.93 OPRD1 (0.45) OPRD1CTSSCTSKPSMB5PSMB8
SCHEMBL26211704 0.79 OPRD1 (0.45) OPRD1CTSSCTSKOPRM1
SCHEMBL26211758 0.79 OPRD1 (0.49) OPRD1OPRM1
SCHEMBL25475251 0.74 OPRD1 (0.52) OPRD1CTSSCTSKOPRM1OPRK1
SCHEMBL25503977 0.72 PSMB5 (0.48) OPRD1CTSSPSMB5MMP9MMP8
SCHEMBL24765226 0.70 CTSB (0.57) OPRD1MMP9OPRM1OPRK1CTSB
SCHEMBL25475427 0.69 CTSB (0.53) OPRD1PSMB5PSMB8MMP8OPRM1
SCHEMBL24823298 0.69 PSMB5 (0.50) OPRD1CTSSPSMB5OPRM1OPRK1
SCHEMBL24764553 0.69 CTSB (0.54) OPRD1CTSSMMP9OPRM1OPRK1
SCHEMBL24765225 0.69 CTSB (0.54) OPRD1CTSSMMP9OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11746126-B2 Bicyclic peptide ligands with detectable moieties and uses thereof Bicyclerd Limited (GB) 2023-09-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11746126-B2 Bicyclic peptide ligands with detectable moieties and uses thereof VIP, NGLY1, GRPR OPRD1 3256/4885CTSS 1469/4885CTSK 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback